UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.650

Sortiert nach

Single-cell sequencing reveals karyotype heterogeneity in murine and human malignancies

Genome Biology, 2016-05, Vol.17 (1), p.115-115, Article 115

2016

Volltextzugriff (PDF)

The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis

PLoS pathogens, 2010-05, Vol.6 (5), p.e1000879

2010

Volltextzugriff (PDF)

Malnutrition is associated with worse health-related quality of life in children with cancer

Supportive care in cancer, 2015-10, Vol.23 (10), p.3043-3052

2015

Volltextzugriff (PDF)

Chemotherapy Treatment in Pediatric Patients with Acute Myeloid Leukemia Receiving Antimicrobial Prophylaxis Leads to a Relative Increase of Colonization with Potentially Pathogenic Bacteria in the Gut

Clinical infectious diseases, 2009-07, Vol.49 (2), p.262-270

2009

Volltextzugriff (PDF)

Evidence based selection of housekeeping genes

PloS one, 2007-09, Vol.2 (9), p.e898-e898

2007

Volltextzugriff (PDF)

Prognostic impact of white blood cell count in intermediate risk acute myeloid leukemia: relevance of mutated NPM1 and FLT3-ITD

Haematologica (Roma), 2011-09, Vol.96 (9), p.1310-1317

2011

Volltextzugriff (PDF)

Influence of genetic variants in TPMT and COMT associated with cisplatin induced hearing loss in patients with cancer: two new cohorts and a meta-analysis reveal significant heterogeneity between cohorts

PloS one, 2014-12, Vol.9 (12), p.e115869

2014

Volltextzugriff (PDF)

Growth-factor-driven rescue to receptor tyrosine kinase (RTK) inhibitors through Akt and Erk phosphorylation in pediatric low grade astrocytoma and ependymoma

PloS one, 2015-03, Vol.10 (3), p.e0122555-e0122555

2015

Volltextzugriff (PDF)

Bacteria causing bacteremia in pediatric cancer patients presenting with febrile neutropenia—species distribution and susceptibility patterns

Supportive care in cancer, 2013-09, Vol.21 (9), p.2417-2426

2013

Volltextzugriff (PDF)

Epidermal growth factor receptor is expressed and active in a subset of acute myeloid leukemia

Journal of hematology and oncology, 2016-08, Vol.9 (1), p.64-64, Article 64

2016

Volltextzugriff (PDF)

Mycoplasma contamination of leukemic cell lines alters protein expression determined by reverse phase protein arrays

Cytotechnology (Dordrecht), 2018-12, Vol.70 (6), p.1529-1535

2018

Volltextzugriff (PDF)

Can kinomics and proteomics bridge the gap between pediatric cancers and newly designed kinase inhibitors?

Cellular and Molecular Life Sciences, 2015-10, Vol.72 (19), p.3589-3598

2015

Volltextzugriff (PDF)

Loss of H3K27 methylation identifies poor outcomes in adult-onset acute leukemia

Clinical epigenetics, 2021-01, Vol.13 (1), p.21-21, Article 21

2021

Volltextzugriff (PDF)

Gene expression profiles associated with pediatric relapsed AML

PloS one, 2015-04, Vol.10 (4), p.e0121730-e0121730

2015

Volltextzugriff (PDF)

Chromatin Profiles Are Prognostic of Clinical Response to Bortezomib-Containing Chemotherapy in Pediatric Acute Myeloid Leukemia: Results from the COG AAML1031 Trial

Cancers, 2024-04, Vol.16 (8), p.1448

2024

Volltextzugriff (PDF)

Optimizing VAP scars after childhood cancer treatment: a pilot study

Supportive care in cancer, 2017-12, Vol.25 (12), p.3651-3654

2017

Volltextzugriff (PDF)

Imatinib mesylate is effective in children with chronic myelogenous leukemia in late chronic and advanced phase and in relapse after stem cell transplantation

Leukemia, 2006-02, Vol.20 (2), p.187-192

2006

Volltextzugriff (PDF)

Vascular endothelial growth factor signaling in acute myeloid leukemia

Cellular and molecular life sciences : CMLS, 2013-04, Vol.70 (8), p.1307-1317

2013

Volltextzugriff (PDF)

Discontinuation of imatinib in children with chronic myeloid leukaemia in sustained deep molecular remission: results of the STOP IMAPED study

British journal of haematology, 2019-05, Vol.185 (4), p.718-724

2019

Volltextzugriff (PDF)

RPPA-based proteomics recognizes distinct epigenetic signatures in chronic lymphocytic leukemia with clinical consequences

Leukemia, 2022-03, Vol.36 (3), p.712-722

2022

Volltextzugriff (PDF)

Bortezomib is significantly beneficial for de novo pediatric AML patients with low phosphorylation of the NF‐κB subunit RelA

Proteomics (Weinheim), 2022-03, Vol.16 (2), p.e2100072-n/a

2022

Volltextzugriff (PDF)

Gene expression profiling in the leukemic stem cell-enriched CD34 fraction identifies target genes that predict prognosis in normal karyotype AML

Leukemia, 2011-12, Vol.25 (12), p.1825-1833

2011

Volltextzugriff (PDF)

Insights in dynamic kinome reprogramming as a consequence of MEK inhibition in MLL-rearranged AML

Leukemia, 2014-03, Vol.28 (3), p.589-599

2014

Volltextzugriff (PDF)

Association of polymorphisms in the TLR4 gene with the risk of developing neutropenia in children with leukemia

Leukemia, 2011-06, Vol.25 (6), p.995-1000

2011

Volltextzugriff (PDF)

1 – 25 von 1.650

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.419)
Mit Volltextzugriff
(1.478)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(915)
Life Sciences & Biomedicine
(823)
Humans
(512)
Biological And Medical Sciences
(335)
Female
(278)
Male
(259)
Fundamental And Applied Biological Sciences. Psychology
(180)
Adult
(168)
Medical Sciences
(159)
Child
(154)
Microbiology
(141)
Biotechnology
(124)
Adolescent
(120)
Animals
(118)
Middle Aged
(109)
Industrial Microbiology
(107)
Industriële Microbiologie
(105)
Oncology
(102)
Child, Preschool
(100)
Dentistry
(95)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Single-cell sequencing reveals karyotype heterogeneity in murine and human malignancies

The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis

Malnutrition is associated with worse health-related quality of life in children with cancer

Chemotherapy Treatment in Pediatric Patients with Acute Myeloid Leukemia Receiving Antimicrobial Prophylaxis Leads to a Relative Increase of Colonization with Potentially Pathogenic Bacteria in the Gut

Evidence based selection of housekeeping genes

Prognostic impact of white blood cell count in intermediate risk acute myeloid leukemia: relevance of mutated NPM1 and FLT3-ITD

Influence of genetic variants in TPMT and COMT associated with cisplatin induced hearing loss in patients with cancer: two new cohorts and a meta-analysis reveal significant heterogeneity between cohorts

Growth-factor-driven rescue to receptor tyrosine kinase (RTK) inhibitors through Akt and Erk phosphorylation in pediatric low grade astrocytoma and ependymoma

Bacteria causing bacteremia in pediatric cancer patients presenting with febrile neutropenia—species distribution and susceptibility patterns

Epidermal growth factor receptor is expressed and active in a subset of acute myeloid leukemia

Mycoplasma contamination of leukemic cell lines alters protein expression determined by reverse phase protein arrays

Can kinomics and proteomics bridge the gap between pediatric cancers and newly designed kinase inhibitors?

Loss of H3K27 methylation identifies poor outcomes in adult-onset acute leukemia

Gene expression profiles associated with pediatric relapsed AML

Chromatin Profiles Are Prognostic of Clinical Response to Bortezomib-Containing Chemotherapy in Pediatric Acute Myeloid Leukemia: Results from the COG AAML1031 Trial

Optimizing VAP scars after childhood cancer treatment: a pilot study

Imatinib mesylate is effective in children with chronic myelogenous leukemia in late chronic and advanced phase and in relapse after stem cell transplantation

Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial

Vascular endothelial growth factor signaling in acute myeloid leukemia

Discontinuation of imatinib in children with chronic myeloid leukaemia in sustained deep molecular remission: results of the STOP IMAPED study

RPPA-based proteomics recognizes distinct epigenetic signatures in chronic lymphocytic leukemia with clinical consequences

Bortezomib is significantly beneficial for de novo pediatric AML patients with low phosphorylation of the NF‐κB subunit RelA

Gene expression profiling in the leukemic stem cell-enriched CD34 fraction identifies target genes that predict prognosis in normal karyotype AML

Insights in dynamic kinome reprogramming as a consequence of MEK inhibition in MLL-rearranged AML

Association of polymorphisms in the TLR4 gene with the risk of developing neutropenia in children with leukemia

Suchergebnisse filtern